Powered By
Below is a listing of treatments and therapies for kidney disease. Click on one to read more information or connect with others currently using it.
Empaveli (pegcetacoplan) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults and children ages 12 and older with C3 glomerulopathy (C3G) or…
read moreOverview
Fabhalta is approved by the U.S. Food and Drug Administration (FDA) to reduce proteinuria (excess protein in the urine) in adults with primary immunoglobulin A nephropathy (IgAN) who are at risk of rapid disease…
Overview
Filspari, approved by the U.S. Food and Drug Administration (FDA) in 2023, is prescribed to slow kidney function decline in adults with primary immunoglobulin A nephropathy (IgAN), a condition characterized by…
Tarpeyo (budesonide) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to reduce the loss of kidney function in adults with primary immunoglobulin A…
read moreBecome a member to get even more
Join
Your Privacy Choices
